Dann Tyler M, Spencer Brianna L, Wilhelm Spencer K, Drake Sarah K, Bartlett Robert H, Rojas-Pena Alvaro, Drake Daniel H
Department of Surgery, University of Michigan Medical School, Ann Arbor, Mich.
Department of Surgery, Extracorporeal Life Support Laboratory, University of Michigan Medical School, Ann Arbor, Mich.
JTCVS Open. 2024 Feb 27;18:91-103. doi: 10.1016/j.xjon.2024.02.010. eCollection 2024 Apr.
Donor hearts procured after circulatory death (DCD) may significantly increase the number of hearts available for transplantation. The purpose of this study was to analyze current DCD and brain-dead donor (DBD) heart transplantation rates and characterize organ refusal using the most up-to-date United Network for Organ Sharing (UNOS) and Organ Procurement and Transplantation Network data.
We analyzed UNOS and Organ Procurement and Transplantation Network DBD and DCD candidate, transplantation, and demographic data from 2020 through 2022 and 2022 refusal code data to characterize DCD heart use and refusal. Subanalyses were performed to characterize DCD donor demographics and regional transplantation rate variance.
DCD hearts were declined 3.37 times more often than DBD hearts. The most frequently used code for DCD refusal was neurologic function, related to concerns of a prolonged dying process and organ preservation. In 2022, 92% (1329/1452) of all DCD refusals were attributed to neurologic function. When compared with DBD, DCD donor hearts were more frequently declined as the result of prolonged warm ischemic time (odds ratio, 5.65; 95% confidence interval, 4.07-7.86) and other concerns over organ preservation (odds ratio, 4.06; 95% confidence interval, 3.33-4.94). Transplantation rate variation was observed between demographic groups and UNOS regions. DCD transplantation rates are currently experiencing second order polynomial growth.
DCD donor hearts are declined more frequently than DBD. DCD heart refusals result from concerns over a prolonged dying process and organ preservation. Heart transplantation rates may be substantially improved by ex situ hemodynamic assessment, adoption of normothermic regional perfusion guidelines, and quality initiatives.
循环死亡后获取的供体心脏(DCD)可能会显著增加可用于移植的心脏数量。本研究的目的是使用最新的器官共享联合网络(UNOS)和器官获取与移植网络数据,分析当前DCD和脑死亡供体(DBD)心脏移植率,并对器官拒绝情况进行特征描述。
我们分析了UNOS和器官获取与移植网络2020年至2022年的DBD和DCD候选者、移植及人口统计学数据,以及2022年的拒绝代码数据,以描述DCD心脏的使用和拒绝情况。进行亚分析以描述DCD供体的人口统计学特征和区域移植率差异。
DCD心脏被拒绝的频率比DBD心脏高3.37倍。DCD拒绝最常用的代码是神经功能,这与对延长的死亡过程和器官保存的担忧有关。2022年,所有DCD拒绝中有92%(1329/1452)归因于神经功能。与DBD相比,DCD供体心脏因热缺血时间延长(优势比,5.65;95%置信区间,4.07 - 7.86)和对器官保存的其他担忧(优势比,4.06;95%置信区间,3.33 - 4.94)而更频繁地被拒绝。在不同人口统计学群体和UNOS区域之间观察到移植率差异。DCD移植率目前呈二阶多项式增长。
DCD供体心脏比DBD更频繁地被拒绝。DCD心脏的拒绝是由于对延长的死亡过程和器官保存的担忧。通过体外血流动力学评估、采用常温区域灌注指南和质量改进措施,心脏移植率可能会得到显著提高。